Riccardo Lencioni

ORCID: 0000-0002-8535-6449
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Lung Cancer Treatments and Mutations
  • MRI in cancer diagnosis
  • Pancreatic and Hepatic Oncology Research
  • Endoplasmic Reticulum Stress and Disease
  • Cancer Mechanisms and Therapy
  • Ultrasound and Hyperthermia Applications
  • Colorectal Cancer Treatments and Studies
  • Renal cell carcinoma treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer, Hypoxia, and Metabolism
  • Radiomics and Machine Learning in Medical Imaging
  • Liver physiology and pathology
  • Advanced MRI Techniques and Applications
  • Medical Imaging and Pathology Studies
  • Cardiac Arrhythmias and Treatments
  • Hepatitis C virus research
  • Cancer, Lipids, and Metabolism
  • Hepatitis B Virus Studies
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies
  • Genetic and Kidney Cyst Diseases
  • Multiple and Secondary Primary Cancers

University of Pisa
2014-2025

University of Miami
2015-2024

Sylvester Comprehensive Cancer Center
2015-2024

Miami Heart Research Institute
2020-2023

Azienda Ospedaliera Universitaria Pisana
2010-2023

Cancer Institute (WIA)
2021

Cancer Institute of Florida
2021

Ospedale Cisanello
2008-2015

Memorial Sloan Kettering Cancer Center
2015

Cornell University
2015

Transcatheter arterial chemoembolization (TACE) offers a survival benefit to patients with intermediate hepatocellular carcinoma (HCC). A widely accepted TACE regimen includes administration of doxorubicin-oil emulsion followed by gelatine sponge—conventional TACE. Recently, drug-eluting bead (DC Bead®) has been developed enhance tumor drug delivery and reduce systemic availability. This randomized trial compares conventional (cTACE) DC Bead for the treatment cirrhotic HCC. Two hundred...

10.1007/s00270-009-9711-7 article EN cc-by-nc CardioVascular and Interventional Radiology 2009-11-11

Image-guided tumor ablation has become a well-established hallmark of local cancer therapy. The breadth options available in this growing field increases the need for standardization terminology and reporting criteria to facilitate effective communication ideas appropriate comparison among treatments that use different technologies, such as chemical (eg, ethanol or acetic acid) ablation, thermal therapies radiofrequency, laser, microwave, focused ultrasound, cryoablation) newer ablative...

10.1148/radiol.14132958 article EN Radiology 2014-06-13

PURPOSE: To compare the effectiveness of radio-frequency (RF) thermal ablation with that percutaneous ethanol injection (PEI) for treatment small hepatocellular carcinoma (HCC) in patients cirrhosis. MATERIALS AND METHODS: A series 102 hepatic cirrhosis and either single HCC 5 cm diameter or smaller as many three HCCs each 3 (overall number lesions, 142) randomly received RF (n = 52) PEI 50) sole first-line anticancer treatment. Mean follow-up was 22.9 months ± 9.4 (SD) group 22.4 8.6 group....

10.1148/radiol.2281020718 article EN Radiology 2003-07-01

PURPOSE: To perform a prospective, intention-to-treat clinical trial to determine the long-term survival rates of patients with hepatic cirrhosis and early-stage hepatocellular carcinoma (HCC) in whom percutaneous image-guided radiofrequency (RF) ablation was used as sole first-line anticancer treatment. MATERIALS AND METHODS: The study performed approval ethics committee, written informed consent obtained for all patients. From June 1, 1996, January 2003, 206 (143 men, 63 women; age range,...

10.1148/radiol.2343040350 article EN Radiology 2005-03-01

To evaluate the usefulness of percutaneous radio-frequency (RF) thermal ablation nonresectable hepatocellular carcinoma (HCC) after occlusion tumor arterial supply.Sixty-two patients with cirrhosis and biopsy-proved HCC underwent RF interruption supply by means either hepatic artery a balloon catheter (40 patients) or feeding arteries gelatin sponge particles (22 patients).After single procedure in 56 two procedures six patients, spiral computed tomography (CT) demonstrated nonenhancing area...

10.1148/radiology.217.1.r00se02119 article EN Radiology 2000-10-01

Ultrasound contrast agents (UCA), in conjunction with specific imaging techniques, are increasingly accepted clinical use for diagnostic and post-interventional workup several organs. Presently, there is no guidance document providing a description of essential technical requirements, proposed investigator qualifications, suggested investigational procedures steps, on image interpretation, recommended established indications safety considerations.

10.1055/s-2004-813245 article EN Ultraschall in der Medizin - European Journal of Ultrasound 2004-08-09
Coming Soon ...